The CEOs of the major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, which together control 90% of the U.S. market, and top PBM executives from CVS Health, Cigna Group’s Express Scripts, and UnitedHealth Group Inc’s Optum RX, which control 80% of the prescription drug market, will testify.